Treatment of patients with refractory giardiasis

被引：92

作者：

Nash, TE

Ohl, CA

Thomas, E

Subramanian, G

Keiser, P

Moore, TA

机构：

[1] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA

[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Infect Dis Sect, Winston Salem, NC 27103 USA

[3] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA

[4] Univ Kansas, Sch Med, Dept Internal Med, Wichita, KS 67214 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 01期

关键词：

D O I：

10.1086/320886

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Giardia lamblia is one of the most common parasitic infections. Although standard treatments are usually curative, some immunocompromised patients, including patients with acquired immunodeficiency syndrome as well as healthy patients, have giardiasis that is refractory to recommended regimens. We report our experience with 6 patients with giardiasis, for whom therapy with a combination of quinacrine and metronidazole resulted in cures for 5 of the 6 patients.

引用

页码：22 / 28

页数：7

共 60 条

[1]

AMENT ME, 1972, GASTROENTEROLOGY, V62, P216

[2] STRUCTURE AND FUNCTION OF GASTROINTESTINAL TRACT IN PRIMARY IMMUNODEFICIENCY SYNDROMES - STUDY OF 39 PATIENTS [J].